SMSalman Bin Mahmood

Salman Bin Mahmood

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Salman Bin Mahmood has a total of 6 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Incidence of giant cell arteritis after bisphosphonate exposure: A retrospective cohort study

    by Salman Bin Mahmood, Yuanyuan Ji, Yi Peng, Zaki Abou Zahr

    Objectives Bisphosphonates may cause autoimmune reactions via a cytokine‐mediated acute phase response. A case of giant cell arteritis (GCA) after zoledronate injection was recently reported. We aimed to evaluate this association by reviewing the incidence of GCA after bisphosphonate administration. Methods This was a retrospective study using the medical claims data of elderly patients in the 20% Medicare random sample from 2008‐2014 who had received zoledronate or ibandronate. Patients who had a diagnosis claim of GCA within the past year before receiving either bisphosphonate were excluded. The development of GCA was assessed in 2 ways: GCA diagnosis claim within 28 days of bisphosphonate injection and another claim within 90 days of initial claim; and temporal artery biopsy claim within 28 days of bisphosphonate injection and GCA diagnosis claim within 90 days of biopsy. Due to the Centers for Medicare & Medicaid Services reporting requirements we excluded numbers less than 11 from analysis. Results The incidence of GCA was 0.010% and 0.013% after zoledronate and ibandronate injection respectively. In the zoledronate group incidence was highest in patients aged 75‐85 years (0.011%), in Whites (0.011%), in the northeast census region (0.013%) and higher in females (0.011% vs 0.009%). All GCA cases noted in the ibandronate group involved White females. We are unable to report incidences by age and region due to the paucity of data. Conclusion The incidence of GCA after bisphosphonate injection was not increased compared to the generally reported incidence in the USA.


  • Open Access

    Constrictive Pericarditis Presenting as Bilateral Pleural Effusion: A Report of Two Cases

    by Manesh Kumar Gangwani, Salman B. Mahmood, Fariha Hasan, Javaid A Khan

    Constrictive pericarditis is a rare presentation. We need a very high index of clinical suspicion to diagnose the disease. It most commonly presents secondary to tuberculosis (TB) in the developing world and post-radiation therapy in the developed world. Classically, it presents with symptoms of heart failure and as pericardial thickening or calcification on imaging studies. In hospital settings, constrictive pericarditis is not usually considered as a differential in patients presenting with pleural effusion. According to the literature, associated pleural effusions in cases of constrictive pericarditis could be left-sided. Herein, we present two unusual presentations of cases with bilateral pleural effusions. One of our cases developed constrictive pericarditis with concurrent active tuberculosis. This is a rare presentation because, normally, constrictive pericarditis is a late complication of tuberculosis. We suggest that when dealing with cases of bilateral pleural effusion, the etiology of constrictive pericarditis should be considered.